Article Information
History
- February 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Charlotte V. Hobbs, MD1,*,
- Jan Drobeniuc, MD, PhD2,
- Theresa Kittle, MPH2,
- John Williams, MS1,
- Paul Byers, MD3,
- Subbian S. Panayampalli, PhD2,
- Meagan Stephenson, MPH2,
- Sara S. Kim, MPH2,
- Manish M. Patel, MD2,
- Brendan Flannery, PhD2,
- CDC COVID-19 Response Team,
- CDC COVID-19 Task Force Microbial Pathogenesis and Immune Response Laboratory.
- 1Children’s of Mississippi, University of Mississippi Medical Center, Jackson, Mississippi
- 2CDC COVID-19 Response Team
- 3Mississippi State Department of Health, Jackson, Mississippi
- ↵*Corresponding author
: Charlotte V. Hobbs, Children’s of Mississippi, 2500 North State Street, Jackson, MS 39202; tel (601) 984 5206 ; e-mail chobbs{at}umc.edu
Posted February 08, 2021.
Estimated SARS-CoV-2 Seroprevalence in Children and Adolescents in Mississippi, May Through September 2020
